| Reprogramming captures the genetic and tumorigenic properties of neurofibromatosis type 1 plexiform neurofibromas M Carrió, H Mazuelas, Y Richaud-Patin, B Gel, E Terribas, I Rosas, ... Stem Cell Reports 12 (2), 411-426, 2019 | 42 | 2019 |
| Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromas H Mazuelas, M Magallón-Lorenz, J Fernández-Rodríguez, ... Cell Reports 38 (7), 2022 | 27 | 2022 |
| KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors E Terribas, M Fernández, H Mazuelas, J Fernández-Rodríguez, J Biayna, ... Neuro-oncology advances 2 (Supplement_1), i62-i74, 2020 | 15 | 2020 |
| Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells H Mazuelas, M Carrió, E Serra Stem Cell Research 49, 102068, 2020 | 12 | 2020 |
| Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation J Biayna, H Mazuelas, B Gel, E Terribas, G Dumbovic, I Rosas, ... Scientific Reports 11 (1), 3661, 2021 | 9 | 2021 |
| Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis M Magallón-Lorenz, E Terribas, S Ortega-Bertran, E Creus-Bachiller, ... Iscience 26 (2), 2023 | 7 | 2023 |
| Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas H Mazuelas, M Magallón-Lorenz, I Uriarte-Arrazola, A Negro, I Rosas, ... JCI insight 9 (3), 2024 | 3 | 2024 |
| Generation of human iPSC-derived neurofibromaspheres for in vitro and in vivo uses H Mazuelas, I Uriarte-Arrazola, J Fernández-Rodríguez, ... STAR protocols 4 (2), 102198, 2023 | 1 | 2023 |
| A detailed landscape of genomic alterations in malignant peripheral nerve sheath tumor cell lines challenges the current MPNST diagnosis M Magallon-Lorenz, E Terribas, M Fernández, G Requena, I Rosas, ... bioRxiv, 2022.05. 07.491026, 2022 | 1 | 2022 |
| Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities E Creus‐Bachiller, J Fernández‐Rodríguez, M Magallón‐Lorenz, ... Molecular Oncology 18 (4), 895-917, 2024 | | 2024 |
| MERLIN-DEFICIENT iPSCs AS ANIN VITROMODEL SYSTEM FOR STUDIYNGNF2PATHOGENESIS N Catasús, M Torres-Martin, I Rosas, B Kuebler, G Casals-Sendra, ... | | 2022 |
| Merlin-Deficient iPSCs Show Altered Pluripotency and Constitute a Potential in Vitro Model for NF2-Related Schwannomas N Catasús, M Torres-Martin, A Negro, B Kuebler, I Rosas, G Casals, ... bioRxiv, 2022.12. 14.520389, 2022 | | 2022 |
| Modeling neurofibromatosis type1 neurofibroma composition and formation H Mazuelas Gallego Universitat de Barcelona, 2021 | | 2021 |
| Neuro-Oncology Advances E Terribas, M Fernández, H Mazuelas, J Fernández-Rodríguez, J Biayna, ... | | 2020 |
